Detalles de la búsqueda
1.
No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice despite severe aortic atherosclerosis.
Clin Lab
; 60(10): 1659-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651711
2.
Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus.
Clin Lab
; 58(11-12): 1231-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23289194
3.
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
Circulation
; 122(5): 470-7, 2010 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20644014
4.
Reduction of HDL levels lowers plasma PLTP and affects its distribution among lipoproteins in mice.
Biochim Biophys Acta
; 1791(8): 790-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19422933
5.
Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
Biochim Biophys Acta
; 1791(10): 1031-6, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19524061
6.
Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
Arterioscler Thromb Vasc Biol
; 28(7): 1277-82, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18421000
7.
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis.
Biochim Biophys Acta
; 1771(12): 1429-38, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17980169
8.
Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness.
J Clin Endocrinol Metab
; 93(12): 4860-6, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18782872
9.
Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
Clin Endocrinol (Oxf)
; 68(3): 375-81, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17877759
10.
Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.
Curr Diab Rep
; 8(1): 65-70, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18367001
11.
Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
Biochim Biophys Acta
; 1761(9): 1070-7, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16935026
12.
Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?
Diabetes
; 55(5): 1491-6, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16644710
13.
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Atherosclerosis
; 193(1): 129-34, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16777114
14.
Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender.
Eur J Endocrinol
; 156(3): 387-94, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17322499
15.
Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein.
Biochim Biophys Acta
; 1738(1-3): 48-53, 2005 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-16298159
16.
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
J Clin Endocrinol Metab
; 91(9): 3382-8, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16684835
17.
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.
Diabetes
; 54(12): 3554-9, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16306375
18.
Torcetrapib and coronary events.
N Engl J Med
; 358(17): 1863; author reply 1863-4, 2008 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-18437725
19.
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study.
Circulation
; 105(18): 2159-65, 2002 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-11994249
20.
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
J Clin Endocrinol Metab
; 90(7): 4198-204, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15840744